Keyword Connections

influenza a virus

Journals

4

1 emerging microbes & infections

2 Virology

3 Pathogens (Basel, Switzerland)

4 Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Research Groups

0

No Research Group Connected

Bibliographies

42

1 Evidence of the Presence of Low Pathogenic Avian Influenza A Viruses in Wild Waterfowl in 2018 in South Africa.

2 The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo.

3 Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease.

4 affect of early-life oxygen exposure on proper lung development and response to respiratory viral infections

5 new small-molecule drug design strategies for fighting resistant influenza a

6 virus shedding in co-infections of low pathogenic avian influenza virus ( h6n2 ) and lentogenic newcastle disease virus (la sota) in numida meleagris

7 influenza virus segment composition influences viral stability in the environment

8 immunogenicity and safety of an as03a-adjuvanted h5n1 influenza vaccine in a taiwanese population

9 initial influenza virus replication can be limited in allergic asthma through rapid induction of type iii interferons in respiratory epithelium

10 generation of adaptive immune responses following influenza virus challenge is not compromised by pre-treatment with the tlr-2 agonist pam2cys

11 every breath you take: the impact of environment on resident memory cd8 t cells in the lung

12 in vitro anti-viral activity of psoraleae semen water extract against influenza a viruses

13 amino acid substitution k470r in the nucleoprotein increases the virulence of h5n1 influenza a virus in mammals

14 mucosa-associated lymphoid tissue lymphoma translocation protein 1 positively modulates matrix metalloproteinase-9 production in alveolar macrophages upon toll-like receptor 7 signaling and influenza virus infection

15 Drug resistance in influenza A virus: the epidemiology and management

16 Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase

17 Drug resistance in influenza A virus: the epidemiology and management

18 CD206+ Cell Number Differentiates Influenza A (H1N1)pdm09 from Seasonal Influenza A Virus in Fatal Cases

19 Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity

20 p-STAT1 regulates the influenza A virus replication and inflammatory response in vitro and vivo.

21 Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.

22 Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins

23 Sequential Immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice

24 [The Effects and Mechanisms of Dihydroartemisinin on Influenza A Virus H1N1 Induces TNF-α and IL-6 Expression in Bronchial Epithelial Cells].

25 (-)-Epigallocatechin-3-gallate induces interferon-λ2 expression to anti-influenza A virus in human bronchial epithelial cells (BEAS-2B) through p38 MAPK signaling pathway.

26 Obesity Increases the Duration of Influenza A Virus Shedding in Adults

27 Effect of Clinical and Virological Parameters on the Level of Neutralizing Antibody against Pandemic Influenza A Virus H1N1 2009

28 immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza a virus

29 experimental approaches to study genome packaging of influenza a viruses

30 a case for rimantadine to be marketed in canada for prophylaxis of influenza a virus infection

31 attenuated recombinant influenza a virus expressing hpv16 e6 and e7 as a novel therapeutic vaccine approach.

32 correction: attenuated recombinant influenza a virus expressing hpv16 e6 and e7 as a novel therapeutic vaccine approach.

33 ns segment of a 1918 influenza a virus-descendent enhances replication of h1n1pdm09 and virus-induced cellular immune response in mammalian and avian systems

34 influenza a virus entry: implications in virulence and future therapeutics

35 comparative studies on two tests for detection of avian influenza a virus and newcastle disease virus in co-infected guinea fowl (numida meleagris)

36 Viral load in patients infected with pandemic H1N1 2009 influenza A virus

37 Spread of influenza A virus infection in hospitalised patients with cancer

38 Antiviral agents active against influenza A viruses

39 Resistant influenza A viruses in children treated with oseltamivir: descriptive study

40 Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults

41 Epidemiology of influenza A virus infection in patients with acute or chronic leukemia

42 Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine